XML 31 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2017
STOCK-BASED COMPENSATION  
STOCK-BASED COMPENSATION

NOTE 12 — STOCK-BASED COMPENSATION

 

The Company issues stock options and restricted stock units to employees under Stock Awards Plans approved by stockholders.  Restricted stock units (“RSUs”) are issued to non-employee directors under a  Director Restricted Stock Unit Plan and the 2016 Equity Incentive Plan, and stock options were formally issued to non-employee directors under a Director Stock Option Plan.  Options are awarded with the exercise price equal to the market price on the date of grant and generally become exercisable over three years and expire 10 years after grant.  RSUs granted to employees generally vest over three years.  Director RSUs generally vest over one year.

 

Compensation expense attributable to employee stock options for the first three months of 2017 was approximately $6.9 million ($4.6 million after tax).  The income tax benefit related to this compensation expense was approximately $2.3 million.  Approximately $6.0 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.  Compensation expense attributable to stock options for the first three months of 2016 was approximately $8.9 million ($5.9 million after tax).  The income tax benefit related to this compensation expense was approximately $3.0 million.  Approximately $7.9 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales. 

 

The Company uses historical data to estimate expected life and volatility.  The weighted-average fair value of stock options granted under the Stock Awards Plans was $11.85 and $10.59 per share during the first three months of 2017 and 2016, respectively.  These values were estimated on the respective grant dates using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

 

 

 

 

 

 

 

Stock Awards Plans:

    

 

 

 

 

Three Months Ended March 31,

 

2017

    

2016

    

 

 

 

 

 

 

Dividend Yield

 

1.7

%  

1.8

%

Expected Stock Price Volatility

 

15.8

%  

16.9

%

Risk-free Interest Rate

 

2.2

%  

1.6

%

Expected Life of Option (years)

 

6.7

 

6.7

 

 

A summary of option activity under the Company’s stock plans during the three months ended March 31, 2017 is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock Awards Plans

 

Director Stock Option Plans

 

 

    

 

 

    

Weighted Average

    

 

    

Weighted Average

 

 

 

 

Options

 

Exercise Price

 

Options

 

Exercise Price

 

Outstanding, January 1, 2017

 

 

8,070,444

 

$

56.36

 

281,334

 

$

56.45

 

Granted

 

 

1,607,773

 

 

74.79

 

 —

 

 

 —

 

Exercised

 

 

(452,677)

 

 

40.41

 

 —

 

 

 —

 

Forfeited or expired

 

 

(12,357)

 

 

69.22

 

 

 

 —

 

Outstanding at March 31, 2017

 

 

9,213,183

 

$

60.35

 

281,334

 

$

56.45

 

Exercisable at March 31, 2017

 

 

6,198,605

 

$

54.63

 

255,998

 

$

55.44

 

Weighted-Average Remaining Contractual Term (Years):

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2017

 

 

6.7

 

 

 

 

5.7

 

 

 

 

Exercisable at March 31, 2017

 

 

5.5

 

 

 

 

5.5

 

 

 

 

Aggregate Intrinsic Value:

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2017

 

$

154,089

 

 

 

$

5,802

 

 

 

 

Exercisable at March 31, 2017

 

$

139,129

 

 

 

$

5,536

 

 

 

 

Intrinsic Value of Options Exercised During the Three Months Ended:

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2017

 

$

15,289

 

 

 

$

 —

 

 

 

 

March 31, 2016

 

$

16,973

 

 

 

$

436

 

 

 

 

 

The fair value of options vested during the three months ended March 31, 2017 and 2016 was $16.9 million and $16.3 million, respectively.  Cash received from option exercises was approximately $15.9 million and the actual tax benefit realized for the tax deduction from option exercises was approximately $5.1 million in the three months ended March 31, 2017.  As of March 31, 2017, the remaining valuation of stock option awards to be expensed in future periods was $23.4 million and the related weighted-average period over which it is expected to be recognized is 2.3 years.

 

The fair value of RSU grants is the market price of the underlying shares on the grant date.  A summary of RSU activity as of March 31, 2017, and changes during the three month period then ended, is presented below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Director Restricted

 

 

 

Stock Awards Plans

 

Stock Unit Plan

 

 

 

    

    

Weighted Average

    

 

    

Weighted Average

 

 

 

RSUs

 

Grant-Date Fair Value

 

RSUs

 

Grant-Date Fair Value

 

Nonvested at January 1,  2017

 

72,127

 

$

69.31

 

15,745

 

$

75.56

 

Granted

 

78,276

 

 

73.29

 

 —

 

 

 —

 

Vested

 

(40,963)

 

 

68.29

 

 —

 

 

 —

 

Forfeited

 

 —

 

 

 —

 

 —

 

 

 —

 

Nonvested at March 31, 2017

 

109,440

 

$

72.54

 

15,745

 

$

75.56

 

 

Compensation expense recorded attributable to RSUs for the first three months of 2017 and 2016 was approximately $0.9 million and $1.2 million, respectively.  The fair value of units vested during the three months ended March 31, 2017 and 2016 was $2.8 million and $656 thousand, respectively.  The intrinsic value of units vested during the three months ended March 31, 2017 and 2016 was $3.0 million and $773 thousand, respectively.  As of March 31, 2017, there was $5.6 million of total unrecognized compensation cost relating to RSU awards which is expected to be recognized over a weighted-average period of 2.5 years.

 

The Company has a long-term incentive program for certain employees.  Each award is based on the cumulative total shareholder return of our common stock during a three year performance period compared to a peer group.  The total expected expense related to this program for awards outstanding as of March 31, 2017 is approximately $2.7 million, of which $282 thousand and $1.3 million was recognized in the first three months of 2017 and 2016, respectively.